
GC71392
Lepzacitinib
Also known as ethyl 4-[[(3R)-1-(2-cyanoacetyl)piperidin-3-yl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxylate
Lepzacitinib is a Janus kinase inhibitor targeting to JAK 1/3
ChemicalCAS2321488-47-3MW355.39FormulaC18H21N5O3
- CAS number
- 2321488-47-3
- Molecular weight
- 355.39
- Formula
- C18H21N5O3
- Solubility
- DMSO : 100 mg/mL (281·38 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
- InChIKey
- QQOPOYMFJLUSBI-GFCCVEGCSA-N
- Catalogue number
- GC71392
- Brand
- GLPBIO
Computed properties PubChem CID 138624627 · XLogP 2 · TPSA 111 Ų · H-bond donors 2
- XLogP
- 2
- TPSA
- 111 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 6
- Heavy atoms
- 26
SMILES CCOC(=O)C1=CN=C2C(=C1N[C@@H]3CCCN(C3)C(=O)CC#N)C=CN2
Computed descriptors from PubChem (CID 138624627), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il